MERSANA THERAPEUTICS INC (MRSN)
US59045L1061 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -74.62M | -171.67M | -204.21M | -170.06M | -88.05M | |||
| Depreciation Amortization | 1.68M | 1.52M | 930.00K | 860.00K | 1.01M | |||
| Change In Working Capital | -36.02M | -15.98M | 133.10M | 10.09M | 5.11M | |||
| Interest Paid | 3.50M | 3.38M | 2.46M | 430.00K | 230.00K | |||
| Other non cash items | 13.91M | 17.25M | 20.82M | 19.13M | 7.23M | |||
| OPERATING CASH FLOW | -95.05M | -168.88M | -49.36M | -139.99M | -74.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -520.00K | -2.17M | -2.20M | -650.00K | -470.00K | |||
| Other Investing Activity | -17.90M | 122.05M | -150.52M | 0.00 | 37.50M | |||
| INVESTING CASH FLOW | -18.42M | 119.88M | -152.72M | -650.00K | 37.03M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -197.00K | -262.00K | -270.00K | 61.43M | 62.72M | |||
| Stock Issued/Repurchased | 6.25M | 95.09M | 153.29M | 2.48M | 167.69M | |||
| Other Financing Activity | 0.00 | -150.00K | 0.00 | -260.00K | N/A | |||
| FINANCING CASH FLOW | 6.05M | 94.67M | 153.02M | 63.65M | 230.41M | |||
| CHANGE IN CASH | -107.42M | 45.68M | -49.06M | -76.99M | 192.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -95.05M | -168.88M | -49.36M | -139.99M | -74.70M | |||
| Capital Expenditure | -520.00K | -2.17M | -2.20M | -650.00K | -470.00K | |||
| FREE CASH FLOW | -95.57M | -171.05M | -51.56M | -140.64M | -75.17M | |||
All data in USD